Safety and Efficacy Study of In-111 Pentetreotide to Treat Neuroendocrine Tumors
Clinical trial NCT00442533 · COMPLETED
Trial details
- NCT number
- NCT00442533
- Sponsor
- Radio Isotope Therapy of America
- Status
- COMPLETED
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2005-08-01
- Primary completion
- 2014-08-30
- Enrollment
- 200
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.